New Drug Therapy Could Improve Brain Function and Life Expectancy in ALS Patients
BEER-SHEVA, Israel—Ben-Gurion University of the Negev (BGU) researchers are developing a new therapy for amyotrophic lateral sclerosis (ALS) using part of an existing FDA-approved drug